| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 16/10/2023 | 22:44 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 09/10/2023 | 13:33 | IH Market News | Monday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and more | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 07/10/2023 | 00:21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 06/10/2023 | 22:30 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 06/10/2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 06/10/2023 | 14:30 | Business Wire | Rule 17(e) Announcement - Horizon Therapeutics plc | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 05/10/2023 | 13:40 | Business Wire | Rule 17(d) Announcement – Horizon Therapeutics plc | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 03/10/2023 | 17:15 | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 02/10/2023 | 14:00 | Business Wire | Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 29/09/2023 | 16:00 | Business Wire | New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 26/09/2023 | 15:02 | Business Wire | Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 19/09/2023 | 14:00 | Business Wire | Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 13/09/2023 | 14:00 | Business Wire | Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 06/09/2023 | 22:15 | Business Wire | Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 06/09/2023 | 13:20 | IH Market News | Wednesday’s Wall Street Highlights: Verb Technology, Apple, Alphabet, Warner Bros, and more | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 05/09/2023 | 15:05 | Business Wire | Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 03/09/2023 | 22:24 | KR Market News | 주말 Biz 뉴스 요약: 노보 노디스크, ARM, 디즈니, 암젠 | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 02/09/2023 | 00:07 | KR Market News | 암젠, FTC로부터 278억 달러 호라이즌 거래 승인 획득 | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 01/09/2023 | 20:46 | Dow Jones News | Trending: FTC Ends Challenge of Amgen/Horizon Deal | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 01/09/2023 | 15:20 | PR Newswire (US) | AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 01/09/2023 | 15:20 | Business Wire | Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 28/08/2023 | 23:13 | KR Market News | 인플레이션과 고용 데이터를 앞두고 美 증시 상승 마감 | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 28/08/2023 | 15:06 | IH Market News | Monday’s Wall Street Highlights: Jabil, Xpeng, 3M, Hostess Brands, and more | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 27/08/2023 | 03:12 | KR Market News | 美 FTC, 암젠의 호라이즌에 대한 $278억 거래 차단 중지 | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 23/08/2023 | 14:00 | Business Wire | Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 09/08/2023 | 16:30 | Business Wire | Horizon Therapeutics plc - Rule 2.12 Announcement | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 08/08/2023 | 14:14 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 08/08/2023 | 13:00 | Business Wire | Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 04/08/2023 | 01:10 | KR Market News | 암젠의 분기별 매출 6% 증가, 이익은 추정치 상회 | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 27/07/2023 | 14:00 | Business Wire | Horizon Therapeutics plc Announces 2023 #RAREis Global Advocate Grant Recipients | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |